1Life Healthcare Inc: directors' dealings · United States · SEC (Form 4)

About 1Life Healthcare Inc

1Life Healthcare Inc. (ticker ONEM) was a United States-listed healthcare company, historically traded on the NASDAQ market, and best known under the One Medical brand. Founded in 2007 and headquartered in San Francisco, California, United States, the company built a modern primary-care platform designed to make access to care simpler through a blend of in-person visits, virtual care, and digital tools. Before its acquisition, 1Life Healthcare was not an insurer or drug maker; it was a membership-based healthcare services business focused on the patient relationship and on delivering a more convenient care experience. Operationally, One Medical’s core business centered on primary care for both consumers and employer-sponsored members. Its service set included online scheduling, prescription renewals, access to medical records, 24/7 virtual visits, routine checkups, preventive care, chronic condition management, and selected mental-health support services. The company’s competitive edge came from its technology-enabled model, consumer-friendly workflow, and office-based footprint in multiple major U.S. urban markets. In a fragmented U.S. primary-care landscape, One Medical positioned itself as a premium, membership-oriented alternative to traditional practices. The most important recent milestone in the company’s history was Amazon’s acquisition. The deal was announced in July 2022 and completed on February 22, 2023. From that point onward, One Medical became part of Amazon’s healthcare strategy rather than an independent public equity story. For investors, that transition matters: the equity thesis for ONEM shifted from standalone operating performance to strategic integration, brand value, and potential ecosystem synergies within Amazon Health Services. Amazon has emphasized the combination of One Medical’s in-office care, digital capabilities, and virtual-care services, and later expanded the proposition to U.S. Prime members through a broader health-care benefit. For French, Belgian, and Swiss investors, ONEM is best understood as a U.S. healthcare-platform asset that contributed a differentiated primary-care model to a much larger technology and retail ecosystem. Its appeal was driven by recurring membership economics, a strong consumer brand, and a network of care locations across the United States. The key recent developments are therefore the 2023 closing of the Amazon transaction, the subsequent integration into Amazon’s healthcare offering, and the continued use of the One Medical brand as a strategic customer-facing health platform in the United States.